Hims & Hers Health Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its ...
Latest News
3 days ago · zacks.com
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should KnowIn the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $29.69, marking a +1.24% move from the previous day.
5 days ago · zacks.com
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to KnowHims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
10 days ago · zacks.com
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for InvestorsIn the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $27.71, marking a -4.87% move from the previous day.
10 days ago · benzinga.com
Hims & Hers Defends Subscription Practices And Privacy Disclosures Against LawsuitHims & Hers Health Inc. (NYSE:HIMS) urged a court to throw out a consumer deception lawsuit, asserting that plaintiffs ignored clear, upfront disclosures regarding data privacy, subscription charges, and cancellation policies.
13 days ago · invezz.com
Hims & Hers stock rises 5% as company launches men's weight care in GermanyShares of Hims & Hers Health (HIMS) rose 5% on Tuesday after the telehealth company launched an online weight-management service for men in Germany, expanding its presence in Europe. The new offering allows patients to complete private online consultations and, if eligible, receive prescriptions from clinicians licensed in the European Union, along with ongoing support.
13 days ago · fool.com
Hims Is Reaching the Three Million Member MilestoneThe healthcare industry is ripe for disruption.
17 days ago · zacks.com
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should KnowZacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
19 days ago · zacks.com
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key InsightsIn the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.72, denoting a -6.7% move from the preceding trading day.
19 days ago · zacks.com
Hims & Hers Expands Australian Women's Health Platform With HersHIMS expands into Australia's women's healthcare market with the Hers launch, offering personalized treatments for weight, hormonal health and hair regrowth.
20 days ago · seekingalpha.com
Hims & Hers Health: The Bullish Case Is Hard To Forecast, But It Is AsymmetricalHims & Hers Health is rated a buy, with a fair value estimate of $41 per share versus the current $29.81. I see the market overly discounting HIMS due to regulatory uncertainty, while the Novo partnership could drive over 50% new subscribers annually. Core business assumptions are conservative: 17% revenue CAGR, 18% EBITDA margin by 2030, and peptides modeled as an upside option worth $3 per share in the base case.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove HIMS